Chester County News and Community Website
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) reported that enrollment in its pivotal Phase 3 Alzheimer’s disease trial has reached 85% and remains on track for completion this summer, …
Annovis Nears Full AD Enrollment Ahead of NDA Plans Read More
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) secured up to $60 million in new financing and outlined plans to begin a human influenza challenge trial for its lead antiviral …
Traws Extends Runway With Financing as Flu Trial Nears Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported expanded Phase 2 data for its SkinJect skin cancer therapy and advanced development of its Teverelix prostate cancer program during the …
Medicus Advances Cancer Pipeline as Losses Widen Read More NORTH WALES, PA — Toppoint Holdings Inc. (NYSE American: TOPP) reported higher first-quarter revenue driven by sharp growth in its import and scrap metal transportation businesses, as the trucking and …
Toppoint Expands Gulf Presence as Import Revenue Jumps Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) reported first-quarter financial results and outlined plans to advance its autoimmune disease cell therapy program toward potential regulatory filings, while expanding manufacturing …
Cabaletta Advances Pivotal Trials as Cash Runway Extends Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) plans to begin a rolling FDA biologics license application submission next month for its experimental Friedreich’s ataxia treatment nomlabofusp as the …
Larimar Targets FDA Filing for Friedreich’s Ataxia Drug Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (Nasdaq: IPSC) said it remains on track to seek regulatory clearance next year for its experimental type 1 diabetes cell therapy as the company …
Century Advances Diabetes Cell Therapy Toward Human Trials Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) reported a sharp swing to quarterly profit after recognizing revenue tied to a patent litigation settlement involving Moderna, while also receiving FDA …
Arbutus Posts Profit After Moderna Patent Settlement Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) projected stronger second-quarter sales after reporting rising order activity and an expanding backlog, signaling improving demand conditions across parts of the semiconductor …
Vishay Forecasts Stronger Demand as Orders Accelerate Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) said it will expand enrollment in its lead cancer drug trial after closing an oversubscribed $30 million private placement, as early patient …
Aprea Expands Cancer Trial After $30 Million Financing Read More